[LXRX] YoY Quarter Result on 30-Jun-2016 [#Q2]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
04-Aug-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- -9.26%
YoY- -35.76%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Revenue 9,682 13,753 12,053 20,089 376 676 214 88.71%
PBT -23,018 -34,706 -35,059 -38,112 -28,074 -26,028 -29,080 -3.81%
Tax -219 6,097 2,062 1,638 1,655 435 -333 -6.74%
NP -23,018 -34,706 -35,059 -38,112 -28,074 -26,028 -29,080 -3.81%
Tax Rate - - - - - - - -
Total Cost 32,700 48,459 47,112 58,201 28,450 26,704 29,294 1.84%
Ratio Analysis
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
NP Margin -237.74 -252.35 -290.87 -189.72 -7,466.49 -3,850.30 -13,588.79 -49.03%
Per Share
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
EPS -0.22 -0.33 -0.33 -0.37 -0.27 -0.35 -0.40 -9.47%
EPS Diluted -0.22 -0.33 -0.33 -0.37 -0.27 -0.35 -0.40 -9.47%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.